Treatment and management of psoriasis.
Rogers
S
S
D000287:Administration, Topical; D000875:Anthralin / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007167:Immunotherapy; D007641:Keratolytic Agents / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008825:Miconazole / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy* / Q000276:immunology; D012176:Retinoids
D000875:Anthralin; D000893:Anti-Inflammatory Agents; D006854:Hydrocortisone; D007641:Keratolytic Agents; D008727:Methotrexate; D008825:Miconazole; D009539:Nicotinic Acids; C086827:tazarotene; D012176:Retinoids